The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Stereotactic radiotherapy +/- HDR boost for unfavorable-risk prostate cancer: Comparison of efficacy, survival, and late toxicity outcomes.
 
Andrew Loblaw
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Sanofi; Tersera
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Sanofi; TerSera
Research Funding - Tersera
Patents, Royalties, Other Intellectual Property - Prostate immobilization device (GU-Lok)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology; Sanofi; Tersera
 
Patrick Cheung
Honoraria - TerSera
Consulting or Advisory Role - TerSera
Research Funding - TerSera
 
Danny Vesprini
Honoraria - Tersera
Travel, Accommodations, Expenses - Elekta
 
Stanley K. Liu
No Relationships to Disclose
 
William Chu
No Relationships to Disclose
 
Hans T. Chung
Honoraria - Bayer; Tersera
Consulting or Advisory Role - Elekta
 
Gerard Morton
No Relationships to Disclose
 
Bindu Musunuru
No Relationships to Disclose
 
Andrea Deabreu
No Relationships to Disclose
 
Melanie Davidson
No Relationships to Disclose
 
Ananth Ravi
No Relationships to Disclose
 
Joelle Helou
No Relationships to Disclose
 
Ling Ho
No Relationships to Disclose
 
Liying Zhang
No Relationships to Disclose